← Back to Search

Metallic Copper

Copper Linen Exposure for Critical Illness in Critically Ill Patients (IMPACT Trial)

N/A
Waitlist Available
Led By Ebbing Lautenbach, MD,MPH,MSCE
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of icu (must be >48 hours) stay plus 2 additional hospital days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if bed linens and gowns with copper can reduce infections in ICU patients. Copper kills germs on contact, which might help lower the risk of hospital-acquired infections and drug-resistant bacteria. Copper-impregnated surfaces and linens have been studied for their potential to reduce healthcare-associated infections, but results have been mixed.

Eligible Conditions
  • Critically Ill Patients

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of icu (must be >48 hours) stay plus 2 additional hospital days
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of icu (must be >48 hours) stay plus 2 additional hospital days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assessment of intensive care -related hospital-acquired infections or multi-drug resistant organisms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Copper linen exposureExperimental Treatment1 Intervention
Subjects will use copper linens during their hospital stay, consisting of copper hospital gowns, copper bed sheets (top and bottom sheets), and copper pillow covers. A subset of 50 subjects from this arm will be recruited to provide three types of swabs to calculate the microbial burden on copper linens. Linen swabs, anatomical swabs and environmental swabs will be collected from subjects and subject hospital rooms will be collected to do bacteria counts.
Group II: Non-copper linen exposureActive Control1 Intervention
Subjects will not have exposure to copper linens during their hospital stay. They will use the usual hospital linens provided by hospital, not containing copper. A subset of 50 subjects from this arm will be recruited to provide three types of swabs to calculate the microbial burden on copper linens. Linen swabs, anatomical swabs and environmental swabs will be collected from subjects and subject hospital rooms will be collected to do bacteria counts.

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
892 Previous Clinical Trials
22,000,177 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,725,948 Total Patients Enrolled
Ebbing Lautenbach, MD,MPH,MSCEPrincipal InvestigatorUniveristy of Pennsylvania
2 Previous Clinical Trials
415 Total Patients Enrolled

Media Library

Copper Linen Exposure (Metallic Copper) Clinical Trial Eligibility Overview. Trial Name: NCT02627092 — N/A
Critically Ill Patients Research Study Groups: Copper linen exposure, Non-copper linen exposure
Critically Ill Patients Clinical Trial 2023: Copper Linen Exposure Highlights & Side Effects. Trial Name: NCT02627092 — N/A
Copper Linen Exposure (Metallic Copper) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02627092 — N/A
~59 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top